M&A/Shareholder vote/2026/Senti Biosciences Holdings, Inc.
Senti Biosciences Holdings, Inc. SNTI
Celadon Partners SPV 35 Limited bought Senti Biosciences Holdings, Inc. (SNTI), paying holders in cash, a deal worth $60M, completed Oct 21, 2026. Celadon Partners SPV 35 Limited is backed by Celadon Partners, LLC. Clinical-stage biotechnology company developing next-generation cell and gene therapies using gene circuit platform technologies for patients with incurable diseases.
Holders get
Cash
one CVR with respect to each share of the Company's common stock
Deal value
$60M
Expected close
Second half of 2026
Status
Completed
See the filing →
Filed
What has happened
Agreement signed · See the filing
Holders sent the terms and a meeting date
Holders approved the deal · Stockholders approved the Merger Agreement with 15,851,146 votes for and 4,325,620 against, and Majority of the Minority Approval with 6,074,146 votes for and 4,325,620 against. · See the filing
Deal completed · See the filing
The board says
FOR the proposal to adopt the Merger Agreement